Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases.
Cancer
Chronic disease
LncRNA
NF-κB
Non-coding RNA
Journal
Biochimica et biophysica acta. Reviews on cancer
ISSN: 1879-2561
Titre abrégé: Biochim Biophys Acta Rev Cancer
Pays: Netherlands
ID NLM: 9806362
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
13
08
2019
revised:
23
09
2019
accepted:
23
09
2019
pubmed:
23
10
2019
medline:
23
2
2020
entrez:
23
10
2019
Statut:
ppublish
Résumé
The regulation of the pleiotropic transcription factor, nuclear factor-κB (NF-κB) by miRNAs and proteins is extensively studied. More recently, the NF-κB signaling was also reported to be regulated by several long non-coding RNAs (lncRNAs) that constitute the major portion of the noncoding component of the human genome. The common NF-κB associated lncRNAs include NKILA, HOTAIR, MALAT1, ANRIL, Lethe, MIR31HG, and PACER. The lncRNA and NF-κB signaling crosstalk during cancer and other diseases such as cardiomyopathy, celiac disease, cerebral infarction, chronic kidney disease, diabetes mellitus, Kawasaki disease, pregnancy loss, and rheumatoid arthritis. Some NF-κB related lncRNAs can affect gene expression without modulating NF-κB signaling. Most of the lncRNAs with a potential to modulate NF-κB signaling are regulated by NF-κB itself suggesting a feedback regulation. The discovery of lncRNAs have provided a new type of regulation for the NF-κB signaling and thus could be explored for therapeutic interventions. The manner in which lncRNA and NF-κB crosstalk affects human pathophysiology is discussed in this review. The challenges associated with the therapeutic interventions of this crosstalk are also discussed.
Identifiants
pubmed: 31639408
pii: S0304-419X(19)30127-1
doi: 10.1016/j.bbcan.2019.188316
pmc: PMC7775411
mid: NIHMS1656208
pii:
doi:
Substances chimiques
MicroRNAs
0
NF-kappa B
0
RNA, Long Noncoding
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
188316Subventions
Organisme : NCI NIH HHS
ID : K22 CA197074
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA036727
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.
Références
Phytomedicine. 2003 Nov;10(8):640-9
pubmed: 14692724
FASEB J. 2015 Jul;29(7):3054-64
pubmed: 25868726
Elife. 2014 Apr 29;3:e01776
pubmed: 24843008
Oncotarget. 2015 Jul 10;6(19):17805-16
pubmed: 26164206
Oncogene. 2016 Oct 13;35(41):5350-5361
pubmed: 27041570
Mol Cell. 2011 Sep 16;43(6):904-14
pubmed: 21925379
EBioMedicine. 2018 Dec;38:162-170
pubmed: 30448228
Mol Cell. 2010 Jun 11;38(5):662-74
pubmed: 20541999
Trends Pharmacol Sci. 2016 Sep;37(9):789-806
pubmed: 27298020
Immunol Rev. 2012 Mar;246(1):205-20
pubmed: 22435557
Eur J Immunol. 2014 Jul;44(7):2085-95
pubmed: 24723426
Mol Med Rep. 2015 Oct;12(4):5611-8
pubmed: 26238267
Mol Med Rep. 2018 Dec;18(6):5742-5750
pubmed: 30365114
Immunity. 2002 Oct;17(4):525-35
pubmed: 12387745
EMBO J. 2010 Sep 15;29(18):3082-93
pubmed: 20729808
Oncotarget. 2016 Sep 20;7(38):62520-62532
pubmed: 27613832
Biochem Biophys Res Commun. 2017 Jun 10;487(4):923-929
pubmed: 28476620
PLoS Genet. 2013 Apr;9(4):e1003373
pubmed: 23593011
Chem Biol Interact. 2019 Feb 25;300:111-122
pubmed: 30611788
Cell. 2010 Aug 6;142(3):409-19
pubmed: 20673990
Ren Fail. 2018 Nov;40(1):527-533
pubmed: 30277425
J Exp Clin Cancer Res. 2017 Apr 12;36(1):51
pubmed: 28403886
N Engl J Med. 2016 Jun 9;374(23):2287-9
pubmed: 27276568
Genes Dev. 2006 Feb 1;20(3):282-96
pubmed: 16452502
J Comput Biol. 2015 Apr;22(4):300-12
pubmed: 25844669
PLoS Genet. 2011 Mar;7(3):e1002008
pubmed: 21408204
Nat Biotechnol. 2015 May;33(5):510-7
pubmed: 25849900
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1002-7
pubmed: 24371310
Eur Rev Med Pharmacol Sci. 2017 Jan;21(2):322-328
pubmed: 28165553
Mol Ther. 2015 Jun;23(6):1034-1043
pubmed: 25743111
Arthritis Rheumatol. 2014 Nov;66(11):2947-57
pubmed: 25077978
Chem Biol Interact. 2018 Apr 1;285:48-58
pubmed: 29481769
J Clin Invest. 2005 Oct;115(10):2625-32
pubmed: 16200195
PLoS Pathog. 2019 Jan 11;15(1):e1007504
pubmed: 30633769
PLoS One. 2017 May 11;12(5):e0177453
pubmed: 28494015
Int Immunopharmacol. 2017 Jun;47:134-140
pubmed: 28391160
Circ Res. 2014 Apr 25;114(9):1389-97
pubmed: 24602777
Cell Prolif. 2019 Jan;52(1):e12525
pubmed: 30362186
Oncotarget. 2017 Jul 11;8(28):46090-46103
pubmed: 28545023
Bioengineered. 2019 Dec;10(1):121-132
pubmed: 30971184
Reprod Sci. 2019 Jan;26(1):18-25
pubmed: 29495908
J Exp Clin Cancer Res. 2015 Jan 22;34:7
pubmed: 25613496
Cell. 2017 Jan 12;168(1-2):37-57
pubmed: 28086098
Mol Cell. 2018 Oct 4;72(1):71-83.e7
pubmed: 30220561
Cell Physiol Biochem. 2018;45(3):1241-1251
pubmed: 29448248
Science. 2006 Jun 16;312(5780):1653-5
pubmed: 16778056
Nat Rev Immunol. 2005 Oct;5(10):749-59
pubmed: 16175180
Biochimie. 2019 Feb;157:48-56
pubmed: 30391287
Nat Commun. 2014 Jun 09;5:3979
pubmed: 24909122
EBioMedicine. 2019 Mar;41:286-298
pubmed: 30797712
J Clin Pathol. 2002 Nov;55(11):801-11
pubmed: 12401816
FEBS Lett. 2016 Sep;590(17):2884-95
pubmed: 27434861
Genes Dev. 2007 Dec 15;21(24):3244-57
pubmed: 18055696
Biochem Biophys Res Commun. 2014 Mar 7;445(2):388-93
pubmed: 24525122
Cancer Biol Med. 2015 Mar;12(1):1-9
pubmed: 25859406
FASEB J. 2016 Mar;30(3):1187-97
pubmed: 26578685
J Immunol. 2017 Jul 15;199(2):547-558
pubmed: 28600289
Eur Rev Med Pharmacol Sci. 2017 Jul;21(13):3113-3119
pubmed: 28742194
Sci Rep. 2017 Dec 22;7(1):18079
pubmed: 29273733
Sci Rep. 2016 Nov 11;6:36843
pubmed: 27833137
Semin Cancer Biol. 2019 Jun;56:12-24
pubmed: 29486318
J Mol Med (Berl). 2013 Jul;91(7):791-801
pubmed: 23529762
Biochem Biophys Res Commun. 2015 Sep 18;465(2):225-31
pubmed: 26248136
Stem Cells. 2016 Nov;34(11):2707-2720
pubmed: 27334046
Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1421-1427
pubmed: 30794866
Mol Med Rep. 2018 May;17(5):7313-7318
pubmed: 29568965
Hum Mol Genet. 2008 Mar 15;17(6):806-14
pubmed: 18048406
Elife. 2013 Jul 23;2:e00762
pubmed: 23898399
Oncotarget. 2017 Feb 21;8(8):13690-13702
pubmed: 28099146
Cancer Biol Ther. 2014 Jun 1;15(6):806-14
pubmed: 24658096
BMC Genomics. 2014 Jun 10;15:460
pubmed: 24917243
Int J Cancer. 2017 May 1;140(9):1955-1967
pubmed: 27925173
Cell. 1986 Dec 26;47(6):921-8
pubmed: 3096580
Science. 2013 Aug 16;341(6147):789-92
pubmed: 23907535
J Immunol. 2017 Jul 15;199(2):581-588
pubmed: 28626066
Cancer Discov. 2011 Nov;1(6):469-71
pubmed: 22586649
Cancer Res. 2015 Apr 1;75(7):1322-31
pubmed: 25600645
Oncol Res. 2018 Jun 11;26(5):753-764
pubmed: 28810936
Biochem Biophys Res Commun. 2018 Jun 2;500(2):518-524
pubmed: 29678575
J Immunol. 2014 Oct 15;193(8):3959-65
pubmed: 25225667
Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2738-2749
pubmed: 30251663
J Immunol. 2015 Aug 15;195(4):1359-63
pubmed: 26179904
Methods Mol Biol. 2017;1513:83-100
pubmed: 27807832
Cell Death Dis. 2016 Aug 11;7(8):e2327
pubmed: 27512949
Nat Med. 2015 Nov;21(11):1253-61
pubmed: 26540387
Mol Cell. 2014 Jun 5;54(5):777-90
pubmed: 24857549
Cell. 2002 Apr;109 Suppl:S81-96
pubmed: 11983155
Cell Physiol Biochem. 2017;42(3):1153-1164
pubmed: 28668956
Annu Rev Immunol. 1998;16:225-60
pubmed: 9597130
Genes Dev. 2004 Sep 15;18(18):2195-224
pubmed: 15371334
F1000Res. 2015 Apr 22;4:96
pubmed: 26069731
Am J Physiol Lung Cell Mol Physiol. 2019 Jul 1;317(1):L87-L98
pubmed: 31042084
Nat Immunol. 2011 Jun 19;12(8):709-14
pubmed: 21772279
Mol Med Rep. 2018 May;17(5):7388-7394
pubmed: 29568924
EMBO J. 2017 Dec 1;36(23):3483-3500
pubmed: 29046333
Tumour Biol. 2015 May;36(5):3355-9
pubmed: 25613066
Tumour Biol. 2016 Mar;37(3):3879-86
pubmed: 26476537
Nature. 2003 Aug 14;424(6950):797-801
pubmed: 12917690
Cell Mol Life Sci. 2019 May;76(10):1947-1966
pubmed: 30879091
Sci Rep. 2015 Nov 02;5:15972
pubmed: 26522444
Cell Death Dis. 2016 Mar 31;7:e2173
pubmed: 27031970
Arthritis Rheumatol. 2016 Apr;68(4):845-56
pubmed: 27023358
Nature. 2009 Mar 12;458(7235):223-7
pubmed: 19182780
Nat Commun. 2014 Apr 07;5:3596
pubmed: 24710105
Anticancer Res. 2011 Dec;31(12):4359-67
pubmed: 22199301
Carcinogenesis. 2017 Oct 1;38(10):1036-1046
pubmed: 29048549
Biosci Rep. 2019 Jul 5;39(7):
pubmed: 31147452
Biochem Biophys Res Commun. 2016 Feb 26;471(1):240-6
pubmed: 26806307
Nat Commun. 2015 Apr 24;6:6967
pubmed: 25908244
J Exp Clin Cancer Res. 2017 Apr 17;36(1):54
pubmed: 28412955
Oncotarget. 2014 Nov 30;5(22):11091-102
pubmed: 25526029
J Immunol. 2017 Nov 15;199(10):3571-3582
pubmed: 28993514
Int Immunopharmacol. 2019 Jan;66:354-361
pubmed: 30521964
FASEB J. 2017 Mar;31(3):1215-1225
pubmed: 27979905
Oncogene. 2003 Sep 11;22(39):8031-41
pubmed: 12970751
J Cell Mol Med. 2015 Jun;19(6):1418-25
pubmed: 25787249
Int Immunopharmacol. 2017 Sep;50:283-290
pubmed: 28732288
Cancer Cell. 2015 Mar 9;27(3):370-81
pubmed: 25759022
J Hepatol. 2016 Jun;64(6):1283-94
pubmed: 26812074
Cell Physiol Biochem. 2018;45(2):844-855
pubmed: 29414815
Cell. 2008 Feb 8;132(3):344-62
pubmed: 18267068
Am J Cancer Res. 2017 Jan 01;7(1):28-40
pubmed: 28123845
Oncogene. 2019 Mar;38(12):2020-2041
pubmed: 30467380
RNA Biol. 2016;13(1):98-108
pubmed: 26618242
Science. 2010 Feb 26;327(5969):1135-9
pubmed: 20185725
Oncotarget. 2017 Mar 7;8(10):17347-17359
pubmed: 28060742
Cell. 2005 Dec 16;123(6):1079-92
pubmed: 16360037
PLoS Genet. 2013;9(7):e1003588
pubmed: 23861667
J Immunol. 2016 Mar 15;196(6):2799-2808
pubmed: 26880762